Clinical Practice Guidelines and other guidance (“Guidance”) provided by ASCO is not a comprehensive or definitive guide to treatment options. It is intended for voluntary use by providers and should be used in conjunction with independent professional judgment. Guidance may not be applicable to al...
Clinical Practice Guidelines and other guidance (“Guidance”) provided by ASCO is not a comprehensive or definitive guide to treatment options. It is intended for voluntary use by providers and should be used in conjunction with independent professional judgment. Guidance may not be applicable to al...
Clinical Practice Guidelines and other guidance (“Guidance”) provided by ASCO is not a comprehensive or definitive guide to treatment options. It is intended for voluntary use by providers and should be used in conjunction with independent professional judgment. Guidance may not be applicable to al...
[3]NCCN Clinical Practice Guidelines in Breast Cancer.Version 2.2024. [4]Grace Mei Yee Choong et al., The impact of adjuvant endocrine therapy (AET) omission in ER-low (1-10%) early-stage breast cancer.. JCO 42, 513-513(2024). [5]Cai, Y. W., Shao, Z. M., & Yu, K. D. (...
[15]Elad, S., Cheng, K. K. F., Lalla, R. V., et al. (2020). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 126(19), 4423–4431. [16]H.S. Rug...
ASCO clinical practice guidelines on tumor markers in breast and colerectal cancerasco clinical practice guidelines on tumor markers in breast and colerectal cancerdoi:10.1016/S0959-8049(97)81959-4Elsevier BVEuropean Journal of Cancer
The American Society of Clinical Oncology (ASCO) has issued its first clinical practice guideline on invasive cervical cancer. Because of the wide global disparities in both screening and care, the guideline is "resource-stratified," and gives treatment recommendations that are tailored to the ...
In 1996, the National Comprehensive Cancer Network®published its first set of Clinical Practice Guidelines in Oncology (NCCN Guidelines®) covering eight tumor types. Guidelines are now published for more than 60 tumor types, subtypes, and topics. During the NCCN’s 28th Annual Conference, upda...
7.NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®),Non-Small Cell Lung Cancer. 2024v5 8.中国临床肿瘤学会工作委员会.中国临床肿瘤学会(CSCO)原发性肺癌诊疗指南2024.人民卫生出版社 9.Aakash Desai,et,al.Lung Cancer. 2022...
[15]Elad, S., Cheng, K. K. F., Lalla, R. V., et al. (2020). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 126(19), 4423–4431. [16]H.S. Rugo, E. Tokunaga, H. Iwata, et al. Pooled analysis of trastuzumab der...